Evidence map›Paper›PMID 35542324›Full record

ArticleRSC advances2018

Antidiabetic and hypolipidemic activities of eburicoic acid, a triterpenoid compound from

Cheng-Hsiu Lin, Yueh-Hsiung Kuo, Chun-Ching Shih

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Anti-Inflammatory Effect of Medicinal FungusFood technology and biotechnology · 2024
    Article
  4. Antidiabetic and Immunoregulatory Activities of Extract ofInternational journal of molecular sciences · 2023
    Article
  5. Antidiabetic and antihyperlipidemic activities ofFood & nutrition research · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Cheng-Hsiu LinDepartment of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare Fengyuan District Taichung City 42055 Taiwan keny71@pchome.com.tw.
Yueh-Hsiung KuoDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University Taichung City 40402 Taiwan kuoyh@mail.cmu.edu.tw.
Chun-Ching ShihGraduate Institute of Biotechnology and Biomedical Engineering, College of Health Science, Central Taiwan University of Science and Technology No. 666 Buzih Road, Beitun District Taichung City 40601 Taiwan ccshih@ctust.edu.tw +886-4-22394256.ORCID https://orcid.org/0000-0003-4264-2602
China Medical University · TWCzech Academy of Sciences, Institute of Biotechnology · CZMinistry of Health and Welfare · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study is designed to examine the potential effects and underlying mechanisms of eburicoic acid (TRR), a compound from

Identifiers

PMID35542324
PMCPMC9080793
OpenAlexW2807043416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.